Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laupacis

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Hospital Quarterly|September 4, 2001
Aramark profile: Andreas Laupacis. Interview by Cynthia MartinA Laupacis
Lancet (London, England)|April 15, 1995
Research by collaborationA Laupacis
The Journal of Bone and Joint Surgery. American Volume|August 1, 1989
The validity of survivorship analysis in total joint arthroplastyA Laupacis
Seminars in Nephrology|March 1, 1990
Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study GroupA Laupacis
Seminars in Hematology|April 1, 1996
Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgeryA Laupacis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 13, 1998
Alternatives to blood transfusion are risky tooA Laupacis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 1996
Preventive therapies: weighing the pros and consA Laupacis
Transplantation Proceedings|April 1, 1991
A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study GroupA Laupacis
Archives of Internal Medicine|February 10, 1997
Methodological studies of systematic reviews: is there publication bias?A Laupacis
The Canadian Journal of Cardiology|June 17, 1998
Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5A Laupacis
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Hospital Quarterly|September 4, 2001
Aramark profile: Andreas Laupacis. Interview by Cynthia MartinA Laupacis
Lancet (London, England)|April 15, 1995
Research by collaborationA Laupacis
The Journal of Bone and Joint Surgery. American Volume|August 1, 1989
The validity of survivorship analysis in total joint arthroplastyA Laupacis
Seminars in Nephrology|March 1, 1990
Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study GroupA Laupacis
Seminars in Hematology|April 1, 1996
Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgeryA Laupacis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 13, 1998
Alternatives to blood transfusion are risky tooA Laupacis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 1996
Preventive therapies: weighing the pros and consA Laupacis
Transplantation Proceedings|April 1, 1991
A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study GroupA Laupacis
Archives of Internal Medicine|February 10, 1997
Methodological studies of systematic reviews: is there publication bias?A Laupacis
The Canadian Journal of Cardiology|June 17, 1998
Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5A Laupacis
Pageof 17